Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Gilligan's Island Buy Setup | Bullish Swing Setup | 2.01% | |
| Gapped Down | Weakness | 2.01% | |
| Oversold Stochastic | Weakness | 2.01% | |
| Oversold Stochastic | Weakness | 0.95% | |
| Gapped Up | Strength | -0.22% | |
| Oversold Stochastic | Weakness | -0.22% | |
| Slingshot Bearish | Bearish Swing Setup | 0.80% | |
| Bullish Engulfing | Bullish | 0.80% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 7 hours ago |
| 60 Minute Opening Range Breakout | about 9 hours ago |
| Up 1% | about 9 hours ago |
| Gilligan's Island Bullish Entry | about 10 hours ago |
| Rose Above Previous Day's High | about 10 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 38.8 |
| 52 Week Low | 23.1558 |
| Average Volume | 11,955 |
| 200-Day Moving Average | 30.68 |
| 50-Day Moving Average | 34.86 |
| 20-Day Moving Average | 33.10 |
| 10-Day Moving Average | 32.08 |
| Average True Range | 0.70 |
| RSI (14) | 40.12 |
| ADX | 27.97 |
| +DI | 24.65 |
| -DI | 41.13 |
| Chandelier Exit (Long, 3 ATRs) | 33.78 |
| Chandelier Exit (Short, 3 ATRs) | 33.11 |
| Upper Bollinger Bands | 35.33 |
| Lower Bollinger Band | 30.87 |
| Percent B (%b) | 0.29 |
| BandWidth | 13.50 |
| MACD Line | -0.86 |
| MACD Signal Line | -0.79 |
| MACD Histogram | -0.0705 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 32.98 | ||||
| Resistance 3 (R3) | 32.89 | 32.52 | 32.84 | ||
| Resistance 2 (R2) | 32.52 | 32.32 | 32.57 | 32.80 | |
| Resistance 1 (R1) | 32.34 | 32.19 | 32.43 | 32.43 | 32.75 |
| Pivot Point | 31.98 | 31.98 | 32.03 | 32.03 | 31.98 |
| Support 1 (S1) | 31.80 | 31.77 | 31.89 | 31.89 | 31.57 |
| Support 2 (S2) | 31.44 | 31.65 | 31.48 | 31.53 | |
| Support 3 (S3) | 31.26 | 31.44 | 31.48 | ||
| Support 4 (S4) | 31.35 |
